Logo image of LASE

LASER PHOTONICS CORP (LASE) Stock Fundamental Analysis

USA - NASDAQ:LASE - US51807Q1004 - Common Stock

3.91 USD
-0.69 (-15%)
Last: 9/29/2025, 8:00:02 PM
3.91 USD
0 (0%)
After Hours: 9/29/2025, 8:00:02 PM
Fundamental Rating

1

Overall LASE gets a fundamental rating of 1 out of 10. We evaluated LASE against 129 industry peers in the Machinery industry. LASE has a bad profitability rating. Also its financial health evaluation is rather negative. LASE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LASE had negative earnings in the past year.
LASE had a negative operating cash flow in the past year.
In multiple years LASE reported negative net income over the last 5 years.
LASE had negative operating cash flow in 4 of the past 5 years.
LASE Yearly Net Income VS EBIT VS OCF VS FCFLASE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M

1.2 Ratios

With a Return On Assets value of -64.04%, LASE is not doing good in the industry: 91.47% of the companies in the same industry are doing better.
The Return On Equity of LASE (-149.96%) is worse than 86.82% of its industry peers.
Industry RankSector Rank
ROA -64.04%
ROE -149.96%
ROIC N/A
ROA(3y)-26.76%
ROA(5y)-14.34%
ROE(3y)-39.66%
ROE(5y)-21.67%
ROIC(3y)N/A
ROIC(5y)N/A
LASE Yearly ROA, ROE, ROICLASE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

LASE's Gross Margin of 45.04% is amongst the best of the industry. LASE outperforms 86.05% of its industry peers.
In the last couple of years the Gross Margin of LASE has declined.
LASE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.82%
GM growth 5YN/A
LASE Yearly Profit, Operating, Gross MarginsLASE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

2

2. Health

2.1 Basic Checks

LASE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LASE has been increased compared to 1 year ago.
There is no outstanding debt for LASE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LASE Yearly Shares OutstandingLASE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M
LASE Yearly Total Debt VS Total AssetsLASE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

LASE has an Altman-Z score of 2.36. This is not the best score and indicates that LASE is in the grey zone with still only limited risk for bankruptcy at the moment.
LASE has a Altman-Z score of 2.36. This is comparable to the rest of the industry: LASE outperforms 43.41% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that LASE is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.12, LASE is in the better half of the industry, outperforming 77.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 2.36
ROIC/WACCN/A
WACC9.88%
LASE Yearly LT Debt VS Equity VS FCFLASE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

LASE has a Current Ratio of 0.82. This is a bad value and indicates that LASE is not financially healthy enough and could expect problems in meeting its short term obligations.
LASE's Current ratio of 0.82 is on the low side compared to the rest of the industry. LASE is outperformed by 93.02% of its industry peers.
A Quick Ratio of 0.41 indicates that LASE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.41, LASE is doing worse than 92.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.41
LASE Yearly Current Assets VS Current LiabilitesLASE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

LASE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -174.99%.
LASE shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.95%.
LASE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.59% yearly.
EPS 1Y (TTM)-174.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)43.95%
Revenue growth 3Y-6.59%
Revenue growth 5YN/A
Sales Q2Q%208.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LASE Yearly Revenue VS EstimatesLASE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LASE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LASE Price Earnings VS Forward Price EarningsLASE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LASE Per share dataLASE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LASE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LASER PHOTONICS CORP

NASDAQ:LASE (9/29/2025, 8:00:02 PM)

After market: 3.91 0 (0%)

3.91

-0.69 (-15%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-15 2025-08-15
Earnings (Next)11-10 2025-11-10
Inst Owners3.61%
Inst Owner Change-31.85%
Ins Owners1.33%
Ins Owner Change0%
Market Cap55.83M
AnalystsN/A
Price TargetN/A
Short Float %9.9%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.25
P/FCF N/A
P/OCF N/A
P/B 8.15
P/tB 37.3
EV/EBITDA N/A
EPS(TTM)-0.92
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.68
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS0.35
BVpS0.48
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -64.04%
ROE -149.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.04%
FCFM N/A
ROA(3y)-26.76%
ROA(5y)-14.34%
ROE(3y)-39.66%
ROE(5y)-21.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.82%
GM growth 5YN/A
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.86%
Cap/Sales 4.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.41
Altman-Z 2.36
F-Score3
WACC9.88%
ROIC/WACCN/A
Cap/Depr(3y)47.74%
Cap/Depr(5y)2746.81%
Cap/Sales(3y)7.88%
Cap/Sales(5y)43.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-174.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)43.95%
Revenue growth 3Y-6.59%
Revenue growth 5YN/A
Sales Q2Q%208.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-125.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-312.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-320.96%
OCF growth 3YN/A
OCF growth 5YN/A